Role of Jatamansi-moola churna in Hypertension

Evaluate the efficacy of Jatamansi-moola Churna in disintegration of pathogenesis of Vyana Bala Vaishamya (Hypertension) - A Single arm clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052986

Enrollment

Registered

2023-05-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex with age between 18-50years. Newly diagnosed stage 1 Primary Hypertensive patients.

Exclusion criteria

Exclusion criteria: Primary Hypertension other than Stage 1 e.g. Stage 2 , Benign Hypertension , Malignant Hypertension , Isolated Hypertension. Secondary Hypertension. Stage 1, Primary Hypertension patients on regular medications. Stage 1, Primary Hypertension patients with co morbidities. Pregnant women and lactating mother. Gestational Hypertension.

Design outcomes

Primary

Measure	Time frame
Improvement in the symptoms of Vyana Bala Vaishamya(Hypertension). Reduction in the Blood Pressure readings, will be assessed on 15th and 30th day.Timepoint: Improvement in the symptoms of Vyana Bala Vaishamya(Hypertension) and blood pressure readings will be assessed for 30 days.	—

Secondary

Measure	Time frame
The study will provide cost effective , safe drug with lesser side effects.Timepoint: Duration of study-12 Months. The outcome will be assessed at 15th and 30th day of study.	—

Countries

India

Contacts

Public ContactDr Ashok Kumar Madan Singh

Chaudhary Brahm Prakash Ayurveda Charak Sansthan

ashokdagar01@gmail.com9899867606

Outcome results